Literature DB >> 12919931

Alterations in rat coronary vasoreactivity and vascular protein kinase C isoforms in Type 1 diabetes.

M M Tickerhoof1, P A Farrell, D H Korzick.   

Abstract

Vascular complications associated with diabetes mellitus (DM) have been linked to activation of PKC-dependent signaling pathways in both human and animal models of DM. To determine whether aberrant PKC signaling mechanisms specifically impact the coronary circulation, we assessed isolated coronary artery (CA) responses after the induction of Type 1 DM. Male Sprague-Dawley rats were subjected to partial pancreatectomy (DM; n = 23) and compared with age-matched controls (CTL; n = 19). Vasoreactivity was assessed in single CAs ( approximately 250 microm internal diameter) after abluminal administration of the Gq-dependent vasoconstrictors endothelin (ET)-1 (10(-10)-10(-9) M) and U-44619 (10(-9)-10(-5) M) or the voltage-gated Ca2+ channel agonist BAY K 8644 (10(-9)-10(-5) M) with and without the PKC inhibitor bisindolylmaleimide (Bis; 10(-6) M). Dilator responses to ACh (10(-9)-10(-5) M) were also assessed. ET-1 resulted in significantly greater constriction in the DM versus CTL group (50 +/- 4% vs. 33 +/- 5%, P < 0.0001), whereas responses to U-44619 and BAY K 8644 were similar between groups. Importantly, inhibition of ET-1 and U-44619 constriction by Bis occurred in the DM but not CTL group (P < 0.05). Western blotting on isolated CAs revealed greater levels of PKC-alpha, PKC-beta I, and PKC-beta II by 22%, 15.3%, and 17.6%, respectively, in the DM versus CTL group (P < 0.05), whereas PKC-delta and PKC-epsilon protein levels were unchanged. DM was also associated with attenuated CA dilation after ACh treatment (P < 0.0566) and reductions in endothelial nitric oxide synthase protein levels versus CTL (P < 0.03). These data suggest that Ca2+-dependent PKC signaling pathways, particularly for ET-1, play a greater role in modulating CA vasoconstrictor responses in DM versus CTL. These data further suggest that aberrant CA constrictor and dilator responses are likely to contribute to the coronary vascular pathology associated with DM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12919931     DOI: 10.1152/ajpheart.00394.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  9 in total

1.  Role of the PKC/CPI-17 pathway in enhanced contractile responses of mesenteric arteries from diabetic rats to alpha-adrenoceptor stimulation.

Authors:  Irem Mueed; Lili Zhang; Kathleen M MacLeod
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

2.  Effect of chronic endothelin blockade on PKC isoform distribution in mesenteric arteries from diabetic rats.

Authors:  Jihong Jiang; Lili Zhang; Kathleen M Macleod; John H McNeill
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

3.  Complex modulation of the expression of PKC isoforms in the rat brain during chronic type 1 diabetes mellitus.

Authors:  Francesco Vetri; Rafael Chavez; Hao-Liang Xu; Chanannait Paisansathan; Dale A Pelligrino
Journal:  Brain Res       Date:  2012-10-24       Impact factor: 3.252

4.  Morphological and pharmacological characterization of the porcine popliteal artery: A novel model for study of lower limb arterial disease.

Authors:  Norman E Frederick; Ray Mitchell; Travis W Hein; Pooneh Bagher
Journal:  Microcirculation       Date:  2019-05-07       Impact factor: 2.628

5.  Divergent effects of aging and sex on vasoconstriction to endothelin in coronary arterioles.

Authors:  Amanda J Leblanc; Bei Chen; Patrick J Dougherty; Rafael A Reyes; Robert D Shipley; Donna H Korzick; Judy M Muller-Delp
Journal:  Microcirculation       Date:  2013-07       Impact factor: 2.628

6.  Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation.

Authors:  James T Pearson; Mathew J Jenkins; Amanda J Edgley; Takashi Sonobe; Mandar Joshi; Mark T Waddingham; Yutaka Fujii; Daryl O Schwenke; Hirotsugu Tsuchimochi; Misa Yoshimoto; Keiji Umetani; Darren J Kelly; Mikiyasu Shirai
Journal:  Cardiovasc Diabetol       Date:  2013-08-01       Impact factor: 9.951

7.  Improvement in cardiac function of diabetic rats by bosentan is not associated with changes in the activation of PKC isoforms.

Authors:  Jihong Jiang; Violet Yuen; Hong Xiang; John H McNeill
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.842

Review 8.  Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature.

Authors:  Sharif A Sabe; Jun Feng; Frank W Sellke; M Ruhul Abid
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-03-25       Impact factor: 5.125

Review 9.  New insights into the role of melatonin in diabetic cardiomyopathy.

Authors:  Keming Huang; Xianling Luo; Yi Zhong; Li Deng; Jian Feng
Journal:  Pharmacol Res Perspect       Date:  2022-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.